Product Images Rydapt
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Rydapt NDC 0078-0698 by Novartis Pharmaceuticals Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a clinical trial result for Rydapt (a drug) efficacy in treating a certain condition, compared to a placebo. The study involved 360 patients who were administered Rydapt and 357 patients who were administered a placebo. The HR (Hazard Ratio) of the Rydapt drug is reported to be 0.7 (which is a good result), with a confidence interval of 95%. The P value is 0.016. The table shows the number of patients at different time intervals (given in months) who were still under treatment and their respective groups (Rydapt and Placebo).*
This is a medication called Rydapt (midostaurin), manufactured by Novartis Pharmaceuticals Corporation. It comes in soft capsules containing 25 mg of the active ingredient and should be swallowed whole with water. The usual dosage is specified in the prescribing information. The medication should be stored at room temperature in its original container to protect from moisture, and away from children. Further information can be obtained by visiting the company's website or calling their customer service. The rest of the text contains product codes and manufacturing information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.